The diagnostic value of immunohistochemical staining of the interstitial vascular C4d complement in membranous nephropathy

1. Dahan K. Membranous nephropathy: diagnosis, new insights in pathophysiology, and therapeutic approach. Rev Med Interne. 2016;37(10):674.10.1016/j.revmed.2016.02.00327236434 Search in Google Scholar

2. Ponticelli C, Passerini P. Can prognostic factors assist therapeutic decisions in idiopathic membranous nephropathy. J Nephrol. 2010;23(2):156-63. Search in Google Scholar

3. Ronco P, Debiec H. Pathophysiology of extramembranous glomerulopathies. Fifty years of progress, from laboratory to patient. Biologie aujourd’hui. 2013;207(4):249-59.10.1051/jbio/201302524594573 Search in Google Scholar

4. Debiec H, Hanoy M, Francois A, Guerrot D, Ferlicot S, Johanet C, et al. Recurrent membranous nephropathy in an allograft caused by IgG3κ targeting the PLA2 receptor. J Am Soc Nephrol. 2012;23(12):1949-54.10.1681/ASN.2012060577350737123123401 Search in Google Scholar

5. Filinte D, Arıkan H, Koç M, Kaya H, Özener IC, Akbaş G. The intensity of PLA2R and C4d immunoexpression in primary membranous nephropathy. South Clin Ist Euras. 2020;31(2).10.14744/scie.2019.16056 Search in Google Scholar

6. Debiec H, Ronco P. Immunopathogenesis of membranous nephropathy: an update. Sem Immunopathol. 2014;36(4):381-97.10.1007/s00281-014-0423-y24715030 Search in Google Scholar

7. Torbati PM, Haleh Tavakolian H. Diagostic Accuracy of C4d-IHC in Diagnosis of Membranous Glomerulonephritis. Iran J Kidney Dis. 2020;14(1):20. Search in Google Scholar

8. Kościelska-Kasprzak K, Bartoszek D, Myszka M, Żabińska M, Klinger M. The complement cascade and renal disease. Arch Immunol Ther Exp. 2014;62(1):47-57.10.1007/s00005-013-0254-x389835324030732 Search in Google Scholar

9. Ma H, Sandor DG, Beck LH. The role of complement in membranous nephropathy. Sem Nephrol. 2013;33(6):531-42.10.1016/j.semnephrol.2013.08.004427499624161038 Search in Google Scholar

10. Beck LH, Salant DJ. Membranous nephropathy: recent travels and new roads ahead. Kidney Int. 2010;77(9):765-70.10.1038/ki.2010.3420182413 Search in Google Scholar

11. Cohen D, Colvin RB., Daha MR, Drachenberg CB. Haas M, Nickeleit V, et al. Pros and cons for C4d as a biomarker. Kidney Int. 2012;81(7):628-39.10.1038/ki.2011.497377110422297669 Search in Google Scholar

12. Espinosa M, Ortega R, Sanchez M, Segarra A, Salcedo MT, Gonzalez F, et al. Association of C4d deposition with clinical outcomes in IgA nephropathy. Clin J Am Soc Nephrol. 2014;9(5):897-904.10.2215/CJN.09710913401145524578331 Search in Google Scholar

13. Larsen C P, Messias NC, Silva FG, Messias E, Walker PD. Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies. Mod Pathol. 2013;26(5):709-15.10.1038/modpathol.2012.20723196797 Search in Google Scholar

14. Stangou MJ, Marinaki S, Papachristou E, Liapis G, Pateinakis P, Gakiopoulou H, et al. Histological grading in primary membranous nephropathy is essential for clinical management and predicts outcome of patients. Histopathology. 2019;75(5):660-71.10.1111/his.13955685698331318463 Search in Google Scholar

15. McClish DK. Analyzing a portion of the ROC curve. Med Decis Making. 1989;9(3):190-5.10.1177/0272989X89009003072668680 Search in Google Scholar

16. Glassock RJ. The pathogenesis of idiopathic membranous nephropathy: a 50-year odyssey. Am J Kidney Dis. 2010;56(1):157-67.10.1053/j.ajkd.2010.01.00820378220 Search in Google Scholar

17. Noris M, Remuzzi G. Overview of complement activation and regulation. Semin Nephrol. 2013;33(6):479-92.10.1016/j.semnephrol.2013.08.001382002924161035 Search in Google Scholar

18. Sheerm NS, Risley P, Abe K, Tang Z, Wong W, Lin T, et al. Synthesis of complement protein C3 in the kidney is an important mediator of local tissue injury. FASEB J. 2008;22(4):1065-72.10.1096/fj.07-8719com18039928 Search in Google Scholar

19. Colvin RB. Pathology of chronic humoral rejection. Contrib Nephrol. 2009;162:75-86.10.1159/00017081419001815 Search in Google Scholar

20. Einecke GB, Sis J, Reeve M, Mengel PM, Campbell LG, Hidalgo B, et al. Halloran antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant. 2009;9(11):2520-31.10.1111/j.1600-6143.2009.02799.x19843030 Search in Google Scholar

21. Murata K, Baldwin WM. Mechanisms of complement activation, C4d deposition, and their contribution to the pathogenesis of antibody-mediated rejection. Transpl Rev. 2009;23(3):139-50.10.1016/j.trre.2009.02.005279736819362461 Search in Google Scholar

22. Zwirner J, Felber E, Herzog V, Riethmüller G, Feucht HE. Classical pathway of complement activation in normal and diseased human glomeruli. Kidney Int. 1989;36(6):1069-77.10.1038/ki.1989.3022689750 Search in Google Scholar

23. Zwirner J, Felber E, Burger R, Bitter-Suermann D, Riethmüller G, Feucht HE. Classical pathway of complement activation in mammalian kidneys. Immunology. 1993;80(2):162. Search in Google Scholar

24. Beck Jr LH, Bonegio RGB, Lambeau G, Beck DM, Powell DW, Cummins TD, et al. Salant M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. New Engl J Med. 2009;361(1):11-21.10.1056/NEJMoa0810457276208319571279 Search in Google Scholar

25. Couser WG. Primary membranous nephropathy. CJASN. 2017;12(6):983-97.10.2215/CJN.11761116546071628550082 Search in Google Scholar

26. Ranjan P, Nada R, Jha V, Sakhuja V, Joshi K. The role of C4d immunostaining in the evaluation of the causes of renal allograft dysfunction. Nephrol Dial Transplant. 2008;23(5):1735-41.10.1093/ndt/gfm84318065805 Search in Google Scholar

27. Val-Bernal J, Fernando M, Garijo F, Val D, Rodrigo E, Arias M. C4d immunohistochemical staining is a sensitive method to confirm immunoreactant deposition in formalin-fixed paraffin-embedded tissue in membranous glomerulonephritis. Histol Histopathol. 2011;26(11):1391-7. Search in Google Scholar

28. Espinosa-Hernández M, Ortega-Salas R, López-Andreu M, Gómez-Carrasco JM, Pérez-Sáez MJ, Pérez-Seoane C, et al. C4d as a diagnostic tool in membranous nephropathy. Nefrología (English Edition). 2012;32(4):536. Search in Google Scholar

29. Bichuette CF, Aparecida da Silva C, Rodrigues Helmo F, Reis Machado J, Antônia dos Reis M. Complement System and C4d expression in cases of Membranous nephropathy. Braz J Nephrology. 2017;39(4):370-5. Search in Google Scholar

30. Song YS, Min KW, Kim JH, Kim GH, Park MH. Differential diagnosis of lupus and primary membranous nephropathies by IgG subclass analysis. Clin J Am Soc Nephrol. 2012;7(12):1947-55.10.2215/CJN.04800511351374923024158 Search in Google Scholar

31. Obana M, Nakanishi K, Sako M, Yata N, Nozu K, Tanaka R, et al. Segmental membranous glomerulonephritis in children: comparison with global membranous glomerulonephritis. Clin J Am Soc Nephrol. 2006;1(4):723-9.10.2215/CJN.0121100517699279 Search in Google Scholar

32. Segawa Y, Hisano S, Matsushita M, Fujita T, Hirose S, Takeshita M, et al. IgG subclasses and complement pathway in segmental and global membranous nephropathy. Pediat Nephrol. 2010;25(6):1091-9.10.1007/s00467-009-1439-820151159 Search in Google Scholar

33. Bally S, Debiec H, Ponard D, Dijoud F, Rendu J, Fauré J, et al. Phospholipase A2 receptor–related membranous nephropathy and mannan-binding lectin deficiency. J Am Soc Nephrol. 2016;27(12):3539-44.10.1681/ASN.2015101155511848527153925 Search in Google Scholar

34. Cunningham PN, Quigg RJ. Contrasting roles of complement activation and its regulation in membranous nephropathy. J Am Soc Nephrol. 2005;16(5):1214-22.10.1681/ASN.200501009615800113 Search in Google Scholar

35. Ponticelli C, Glassock RJ. Glomerular diseases: membranous nephropat hy –a modern v iew. Clin J Am Soc Nephrol. 2014;9(3):609-16.10.2215/CJN.04160413394475623813556 Search in Google Scholar

36. Murtas C, Bruschi M, Candiano G, Moroni G, Magistroni R, Magnano A, et al. Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy. Clin J Am Soc Nephrol. 2012;7(9):1394-400.10.2215/CJN.02170312343094622773590 Search in Google Scholar

37. mmunohistochemistry in membranous nephropathy. J Lab Physicians. 2014;6(2):76.10.4103/0974-2727.141500419636725328330 Search in Google Scholar

38. Espinosa-Hernández M, Ortega-Salas R, López-Andreu M, Gómez-Carrasco JM, Pérez-Sáez MJ, Pérez-Seoane C, Aljama-García P. C4d as a diagnostic tool in membranous nephropathy. Nefrología (English Edition). 2012;32(3):295-9. Search in Google Scholar

39. Lim BJ, Kim MS, Kim YS, Kim SI, Jeong HI. C4d deposition and multilayering of peritubular capillary basement membrane in posttransplantation membranous nephropathy indicate its association with antibody-mediated injury. Transplant Proc. 2012;44(3):619-20.10.1016/j.transproceed.2011.12.05222483452 Search in Google Scholar